Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Recruiting 6Active not recruiting 5Completed 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Breast Neoplasms 1223Neoplasms 1041Carcinoma, Non-Small-Cell Lung 755Prostatic Neoplasms 693Colorectal Neoplasms 593Lung Neoplasms 574Pancreatic Neoplasms 402Leukemia, Myeloid, Acute 399Neoplasm Metastasis 387Multiple Myeloma 374Ovarian Neoplasms 372Stomach Neoplasms 317Carcinoma, Hepatocellular 303Melanoma 282Recurrence 281Brain Neoplasms 281Squamous Cell Carcinoma of Head and Neck 268Head and Neck Neoplasms 237Endometrial Neoplasms 235Glioblastoma 234Triple Negative Breast Neoplasms 230Precursor Cell Lymphoblastic Leukemia-Lymphoma 226Uterine Cervical Neoplasms 225Lymphoma 224Hematologic Neoplasms 200Sarcoma 199Urinary Bladder Neoplasms 197Esophageal Neoplasms 191Carcinoma, Renal Cell 190Lymphoma, Non-Hodgkin 176

Interventions

Radiotherapy, Intensity-Modulated 2Gemcitabine 2Taxes 1Radiotherapy 1Panitumumab 1Optical Imaging 1Irinotecan 1Cisplatin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Pancreatic Adenocarcinoma × 1 year × Clear all
NCT07619391 2026-06-02

MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
30 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT05624918 2026-04-08

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Big Ten Cancer Research Consortium

Phase 2 Recruiting
38 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT03384238 2026-03-17

Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Stanford University

Phase 1/2 Recruiting
27 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT06095141 2025-08-07

PTCA199-6

Fudan University

Phase 2/3 Recruiting
30 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT06149689 2025-08-07

PTCA199-7

Fudan University

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT06250972 2025-08-07

PTCA199-11

Fudan University

Phase 3 Recruiting
210 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡